Overexpression of CASC2 mitigated cell apoptosis and the release of inflammatory factors such as IL‐1β, IL‐6, and TNF‐α through the miR‐144/SOCS2 axis, slowing the progression of diabetic nephropathy. This evidence concerns the gene CASC2 and diabetic kidney disease.